PPIST04708
Protein Information
| Protein_Chain | A |
|---|---|
| Protein_Sequence | IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAK |
Peptide Information
| Peptide_Chain | B[auth L] |
|---|---|
| Peptide_Sequence | RKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERR |
| Peptide_Length | 55 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 2XBW |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 1.72 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Discovery of a Factor Xa Inhibitor (3R,4R)-1-(2,2-Difluoro-Ethyl)-Pyrrolidine-3,4-Dicarboxylic Acid 3-[(5-Chloro-Pyridin-2-Yl)-Amide] 4-{[2-Fluoro-4-(2-Oxo-2H-Pyridin-1-Yl)-Phenyl]-Amide} as a Clinical Candidate. |
|---|---|
| Release_Year | 2010 |
| PMID | 20650636 |
| DOI | 10.1016/J.BMCL.2010.06.126 |